Joanna Trus, MD
Obstetrics & Gynecology · Gulfport, MSNPI 1720187354
Payments from drug & device makers
Across 70 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$325
- Amgen$87
- Hologic Sales And Service, LLC$80
- Exeltis, USA Inc.$68
- Therapeuticsmd, Inc.$67
- Organon$62
- plus $538 from 19 others
What the payments were for
- Food & beverage$1,18997%
- Education$383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $325 |
| Amgen | 5 | $87 |
| Hologic Sales And Service, LLC | 4 | $80 |
| Exeltis, USA Inc. | 3 | $68 |
| Therapeuticsmd, Inc. | 5 | $67 |
| Organon | 3 | $62 |
| Baxter Healthcare | 2 | $55 |
| Mayne Pharma Commercial LLC | 4 | $53 |
| Mallinckrodt Enterprises LLC | 3 | $49 |
| Scynexis, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Mylan Pharmaceuticals Inc. | 2 | $35 |
| Avion Pharmaceuticals | 2 | $32 |
| Medtronic | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| AMAG Pharmaceuticals, Inc. | 2 | $24 |
| Lupin Inc. | 2 | $24 |
| Coloplast | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Merz North America, Inc. | 1 | $19 |
| Coopersurgical, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
| Pfizer | 1 | $11 |
How this compares
$1,227 in reported general payments places this provider in the 55th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 131 | $8,278 |
| Clobetasol Propionate | 17 | $1,198 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 53 | $1,095 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 15 | $962 |
| Metronidazole | 16 | $860 |
| Terconazole | 14 | $346 |
| Alendronate Sodium | 49 | $335 |
| Levothyroxine Sodium | 13 | $170 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $130 |
| Medroxyprogesterone Acetate | 20 | $115 |
| Fluconazole | 40 | $100 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Gulfport
- Donald GaddyGulfport$10K
- David TaylorGulfport$7K
- Dona KioseffGulfport$7K
- Michael LivingstonFlowood$2.9M
- Noel DuplantierBay Saint Louis$273K
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$74K
- Melissa BarnettTupelo$50K
- Ahmet BedestaniFlowood$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.